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DNA-Protein Cross-Links as a
Biomarker of Cr(VI) Exposure
We would like to provide some observations
regarding a paper by Zhitkovich et al. (1)
that appeared in EHP Supplements. In this
paper, the authors summarized theirfindings
to date regarding the possible use of
DNA-protein cross-links (DPC) in lympho-
cytes as a biomarker for human exposure to
hexavalent chromium [Cr(VI)]. We believe
that the research ofZhitkovich et al. (1) in
this area is timelyandpossibly ofgreat bene-
fit. Exposure to Cr(VI) in theworkplace and
the environment is clearly an increasing con-
cern on the part of many regulatory agen-
cies; for example, both the Occupational
Safety and Health Administration (OSHA)
and the U.S. Environmental Protection
Agency (EPA) have decided to reevaluate
longstanding Cr(VI) inhalation exposure
standards [the permissible exposure limit
(PEL) and the cancer slope factor]. Also, as
Zhitkovich et al. (1) noted, Cr(VI) is pre-
sent at elevated concentrations in soils and
groundwater at numerous locations in the
United States and elsewhere. However, as
of yet, there does not appear to be a suffi-
ciently reliable technique for biomonitoring
ofCr(VI) exposure. The limitations associ-
ated with urine chromium monitoring have
been discussed in the literature (2), and
hair, nail, and other tissue samples do not
provide a measure of exposure as they do
for other metals. Therefore, development of
a reliable biomarker for low-to-moderate
levels of exposure to Cr(VI) would have
obvious applications in occupational and
environmental settings.
We have preliminarily investigated the
usefulness of a variety of DNA effects as
possible markers of Cr(VI) exposure,
including the DPC lymphocyte assay (3).
Some ofthis work was done in conjunction
with Zhitkovich and his colleagues (4). Our
review of the recent paper by Zhitkovich et
al. (1) and the related manuscripts that have
appeared over the past 10 years suggests that
certain elements regarding the specificity
and sensitivity of the DPC assay have not
been consistently addressed in the literature,
and this has possibly lead to some confusing
and contradictory conclusions regarding the
potential utility of this biomarker. We
would like to take this opportunity to clarify
some of these issues and thereby focus
future research efforts on reducing the
uncertainties associated with this assay.
It is important to note that a causal rela-
tionship between human exposure to Cr(VI)
and increased lymphocyte DPC levels has
not yet been established. In the only pub-
lished study that measured DPC levels in cir-
culating human lymphocytes after exposure
to known doses of Cr(VI), we found that
ingestion of water containing 10 ppm
Cr(VI), which is 100 times the drinking
water standard (0.10 ppm), did not yield an
increase in DPC levels above predosing
"background" levels (5). This is in spite of
the fact that blood and urinary chromium
levels demonstrated that asubstantial fraction
of ingested chromium had been absorbed
[this study was not cited by Zhitkovich et al.
(1)]. Furthermore, in the only occupational
DPC studywhere there was clear evidence of
chromium exposure (chrome platers with
highly elevated blood chromium levels), lym-
phocyte DPC levels were no greater than in
the control group (6). In the other occupa-
tional and environmental Cr(VI) DPC stud-
ies (7-10), all ofwhich reported increased
DPC in the exposed population, chromium
body burdens were measured in the exposed
group only (8-J1), orwere measured in both
the exposed and control groups and found to
be the same (2). In short, no investigator has
yet identified a chromium-exposed popula-
tion that has shown both an increase in lym-
phocyte DPC levels and a chromium body
burden relative to a contemporaneously sam-
pledcontrol group.
The animal data are also inconclusive.
For example, lymphocyte DPC levels were
not increased in rats fed 100-200 ppm
Cr(VI) (1,000-2,000 times the drinking
water standard), even though tissue chromi-
um levels indicated that significant chromi-
um absorption had occurred (11). The in
vivo animal data that support a causal rela-
tionship reported a 2- to 4-fold increase in
lymphocyte DPC in rats injected intraperi-
toneally (ip) with 40 mg/kg chromate (12),
but even these results must be considered in
light of the fact that another investigator
using the same dosing regimen (but a differ-
ent cell preparation technique) showed no
increase in lymphocyte DPC (11).
Accordingly, we believe that additional (and
reproducible) in vivo animal exposure work
should be performed before it can be
concluded that relevant routes of Cr(VI)
exposure can in fact cause elevated lympho-
cyte DPC in an intact organism.
As noted above, increased lymphocyte
DPC levels in animals have been measured
only after ip administration of a Cr(VI)
dose (40 mg/kg chromate) that was highly
toxic if not lethal [the acute oral gavage
median lethal dose (LD50) for chromate
ranges from 13 to 28 mg/kg (13)].
Similarly, several researchers have suggested
that Cr(VI) will induce DPC in animal and
human cells in vitro only at cytotoxic con-
centrations (4). As described in the inter-
laboratory validation study (4),
For chromate, the number of crosslinks was not
increased at concentrations less than those that
caused an inhibition of cell proliferation and
which caused some degree of cell toxicity. At
higher concentrations, crosslinking was directly
related to the increase in long-term cytotoxicity.
Further, none ofthe occupational studies of
Cr(VI)-exposed workers have reported
more than a doubling ofbackground DPC
levels (6-9). The much lower environmen-
tal Cr(VI) exposures might not be sufficient
to induce DPC levels measurably above
those that normally exist. In short, as noted
by Costa et al. (4), it is unclear whether
DPC formation will prove to be sufficiently
sensitive to serve as a reliable biomarker for
most Cr(V1) exposures.
Zhitkovich et al. (1) indicated that their
DPC analysis "has been validated using var-
ious cross-linking agents in cultured cells."
Because we participated in the design and
interpretation of the DPC interlaboratory
validation study (4), we feel that some clari-
fication is appropriate. The study, which
involved five different laboratories testing
many different metal compounds, demon-
strated that while each lab obtained the
same qualitative results regarding which
metals induced DPC (copper, arsenic, and
chromium) and those which did not (mer-
cury, magnesium, permanganate, cadmium,
lead, and aluminum), the actual degree of
DPC measured in each lab was highly vari-
able. For example, the increase in DPC
induced by arsenic trioxide at 150 pm
ranged from 8- to 60-fold. Although several
possibilities for the interlaboratory variabili-
ty were discussed, we believe that it may be
premature to term the DPC assay as "vali-
dated"; we would encourage more research
into the reproducibility ofthe method.
There are some apparent contradictions
in the summary table presented by
Zhitkovich et al. (1); this table (Table 1)
contains the findings of the epidemiologic
studies that have examined DPC levels in
individuals thought to have experienced
Cr(VI) exposure. First, Zhitkovich et al. (1)
state that there were no confounders present
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in any ofthe six studies cited. It is indeed a
rare epidemiologic study that has no con-
founders, much less an accumulated body
of studies. There were, in fact, significant
confounders present in most and probably
all of the studies, which the authors them-
selves described in some detail. For exam-
ple, in the three studies of welders (7-9),
there was coexposure to nickel, a known
cross-linking agent, and a variety of oxides
and metal salts. As noted by Costa et al. (7)
in their study ofwelders,
... the possible presence ofconfounding factors,
such as smoking and diet, reported to be associ-
ated with crosslinks [141 does not allow a defini-
tive conclusion.
In a preliminary report on the same
study, it was noted that "...we did observe
increased cross-linking but are unsure ofthe
agent involved" (15). Also, as noted in the
Bulgarian chrome-plater study (6),
... it is difficult to say with certainty whether the
increase in DPC was due to chromium or some
other chemical.
Confounding factors were also present in the
"environmentally exposed" populations
because their corresponding control groups
were comprised in part [NewJersey (10)] or
completely [Bulgaria (6)] ofindividuals from
rural areas with significantly less industrial
air pollution. In summary, we believe it is
somewhat overreaching to conclude that
these studies were completely free ofall con-
foundingfactors.
Second, there appear to be some con-
flicting conclusions reached in the various
studies, and we believe these warrant more
discussion than given by Zhitkovich et al.
(1). For example, in one study of welders
(7), white blood cell DPC levels were
increased over those of unexposed controls,
but there was no difference in blood chromi-
um levels between the two groups. Costa et
al. (2) assumed apriorithat Cr(VI) exposure
had occurred and suggested that DPC may
therefore be a more sensitive biomarker than
blood chromium concentrations. However,
in the Bulgarian chrome platers (6), blood
chromium levels were significantly elevated
(almost 10-fold) above controls, a clear
indication that chromium exposure had
occurred; yet there was no difference in
DPC levels in the exposed group versus the
control group. These findings are directly
contradictory: DPC was elevated in workers
with negative evidence of Cr(VI) exposure,
and DPC was not elevated in workers with
clear evidence of Cr(VI) exposure. The
findings related to the `environmentally
exposed" groups are also inconsistent. For
example, Table 1 presented by Zhitkovich
et al. (1) indicates that Zhitkovich et al.
(16) measured elevated DPC in a Bulgarian
population (residents ofJambol) that expe-
rienced environmental Cr(VI) exposure.
However, Zhitkovich et al. (16) did not
measure environmental Cr(VI) levels in
Jambol. They simply concluded that the
Jambol residents must have been exposed to
Cr(VI) because their mean blood chromium
level was higher than in residents from
another town (Burgas). Yet this assumption
is internally inconsistent with the fact that
Costa et al. (6) found no difference in DPC
levels between the chrome platers and the
Jambol residents, two groups with tremen-
dous differences in blood chromium levels.
Other such inconsistencies can be found,
and as a result we do not believe the epi-
demiologic evidence is yet sufflicient to con-
clude that DPC is a proven biomarker for
Cr(VI) exposure.
We believe that a simple, rapid, and
reliable biomarker for screening or quanti-
tating Cr(VI) exposure would be a very
valuable tool. For this reason we suggest
that the technical underpinnings of any
proposed Cr(VI) biomarker merits rigorous
evaluation before its acceptance as an accu-
rate technique. Clearly more work should
be done regarding the use ofDPC to char-
acterize exposure to Cr(VI).
DennisJ. Paustenbach
Brent L Finley
Exponent
Menlo Park, California
E-mail: dpaustenbach@Exponent.com
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Dietary Exposure to PCBs
and Dioxins
We read with great interest the paper by
Patandin et al. (1) in which they describe
their efforts to model dietary intake ofcer-
tain highly lipophilic compounds (poly-
chlorinated biphenyls and dioxins) over the
first 25 years of life. In the context of
exploring distributional dosimetry ofbreast
milk contaminants to nursing children (2),
we were particularly interested in the por-
tion of the model that addressed intake to
nursing infants. As a prerequisite of assess-
ing potential adverse health effects, this
information should be extended to estimate
the resulting tissue concentrations.
For estimating tissue concentrations as a
function of age, intake is one of many fac-
tors. Other factors that must be taken into
account include organ and tissue volumes, as
well as elimination parameters and their
respective changes over time. Elimination of
this dass oflipophilic compounds from the
body should reflect both fecal excretion of
the unchanged compound and metabolism
occurring mainly in the liver. Because liver
and tissue volumes, as well as mass offeces,
change drastically during growth, elimina-
tion parameters (represented by half-lives)
cannot be time-independent constants in
the range of several years, as is usually
assumed. A reduced apparent half-life of
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